University of Notre Dame Endowment
The University of Notre Dame is a private Catholic institution located in South Bend, Indiana, renowned for its commitment to academic excellence, faith, and research. Offering a diverse array of undergraduate, graduate, and professional degree programs across fields such as business, engineering, humanities, and sciences, Notre Dame fosters a vibrant community that promotes intellectual development and innovation. The university's endowment fund is managed by its board of trustees, with investment earnings supporting essential initiatives such as scholarships, fellowships, endowed faculty positions, academic programs, and library collections. This endowment plays a crucial role in sustaining the university's mission and enhancing its educational offerings.
Torigen Pharmaceuticals
Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.
AgenDx Biosciences
Seed Round in 2018
AgenDx Biosciences is an early-stage molecular diagnostics company that is developing an innovative, cost-effective platform for molecular diagnostics. This technology enables rapid, lab-quality testing with results available in minutes, transforming disease detection and treatment. The platform supports a variety of nucleic-acid-based tests for conditions such as infectious diseases, cancer, and chronic illnesses like cardiovascular disease and arthritis. Initially, AgenDx aims to validate its technology by creating tests to assist physicians in making treatment decisions for pancreatic cancer. Designed for use in clinical settings by untrained personnel, the system uses disposable cartridges to process samples, which can include blood, saliva, and tissue. An automated control system runs the tests and displays clear results, making it accessible for immediate clinical application.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.